China has the world’s largest iron deficiency anemia population with estimated prevalence of 15%1 Approval may also benefit the Chinese healthcare system, among others through implementation of a more
Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients Therapy recen
Iron Deficiency Day unites a strong international coalition raising awareness on the serious health impact of iron deficiency and iron deficiency anemia1 This year, the focus is on importance of earl
A review decision by the European Medicines Agency (EMA) is expected in the second half of 2023 If approved, sparsentan will be a first-in-class treatment to address the significant unmet medical nee
/newsonfloor/media/post_banners/lfDHb9AXWWi2f9eRgOvg.jpg)
/newsonfloor/media/post_banners/GctJhFFBVk27md2b8hAD.jpg)
/newsonfloor/media/post_banners/rHgTnGXsBf9pULkVgijv.jpg)
/newsonfloor/media/post_banners/Bwj3X4fq4zU8UJb0ZKqW.jpg)
/newsonfloor/media/post_banners/YHKHbR4De3REmxNp3yH3.jpeg)
